Biote News and Activities

Headquarters: United States (USA)

Biote is a company listed under the stock ticker BTMD (US).

View the org chart displaying its 29 main executives

Komal Bajaj has joined the company as Chief Medical Officer (posted on June 1 2026).
Robert Peterson who is Chief Financial Officer and Chief Business Officer, will become Interim Chief Executive Officer and Director on Jun. 8, 2026 (posted on May 28 2026).
Bret Christensen who was Chief Executive Officer, becomes Director (posted on May 28 2026).

Create your alert
to follow the executive moves at Biote.

The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
Tissium has just announced a $60 Million fundraising (posted on July 8 2026).